CSL Of Australia's, Other Lung-Disease Drugs Called 'No Benefit' In Study
This article was originally published in PharmAsia News
Executive Summary
A drug of Australia's CSL for treating chronic lung disease, and similar drugs, all known to be expensive treatments, were declared worthless by a group of scientists